These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35031027)

  • 21. PACE: Pharmacists use the power of communication in paediatric asthma.
    Elaro A; Shah S; Pomare LN; L Armour C; Z Bosnic-Anticevich S
    Int J Clin Pharm; 2014 Oct; 36(5):976-85. PubMed ID: 25087038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rural pharmacists and stakeholders perspectives of expanded pharmacy practice: A descriptive study.
    Taylor SM; Cairns A; Glass BD
    Aust J Rural Health; 2021 Jun; 29(3):341-353. PubMed ID: 34148266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilisation of the PRECEDE-PROCEED model in community pharmacy for health needs assessment: A narrative review.
    Handyside L; Warren R; Devine S; Drovandi A
    Res Social Adm Pharm; 2021 Feb; 17(2):292-299. PubMed ID: 32253124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia.
    Nielsen S; Olsen A
    Int J Drug Policy; 2021 Apr; 90():103061. PubMed ID: 33321285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful implementation and provision of enhanced and extended pharmacy services.
    Hattingh L; Sim TF; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing Core Competencies for Pharmacy Graduates: The Lebanese Experience.
    Sacre H; Hallit S; Hajj A; Zeenny RM; Akel M; Raad E; Salameh P
    J Pharm Pract; 2022 Apr; 35(2):332-339. PubMed ID: 33084476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applying action research in pharmacy practice.
    Saramunee K
    Res Social Adm Pharm; 2022 Jan; 18(1):2164-2169. PubMed ID: 34147371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining professional pharmacy services in community pharmacy.
    Moullin JC; Sabater-Hernández D; Fernandez-Llimos F; Benrimoj SI
    Res Social Adm Pharm; 2013; 9(6):989-95. PubMed ID: 23591411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies.
    Benrimoj SI; Werner JB; Raffaele C; Roberts AS
    Pharm World Sci; 2008 Apr; 30(2):147-53. PubMed ID: 17939057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behaviours that contribute to pharmacist professionalism: a scoping review.
    Mill D; Page AT; Johnson J; Lloyd R; Salter S; Lee K; Seubert L; Clifford RM; D'Lima D
    BMJ Open; 2023 Jun; 13(6):e070265. PubMed ID: 37369416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study.
    Yong FR; Hor SY; Bajorek BV
    BMC Health Serv Res; 2021 Sep; 21(1):906. PubMed ID: 34479542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital pharmacists' ethical exposure and decision-making.
    So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL
    Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
    Siu AHY; Krass I; Mitchell B; McNamara K
    Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evidence-led review of the FIP global competency framework for early career pharmacists training and development.
    Bajis D; Al-Haqan A; Mhlaba S; Bruno A; Bader L; Bates I
    Res Social Adm Pharm; 2023 Mar; 19(3):445-456. PubMed ID: 36446714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacy practice in the domain of assisted dying: A mapping review of the literature.
    Woods P; Schindel TJ; King MA; Mey A
    Res Social Adm Pharm; 2020 Mar; 16(3):267-276. PubMed ID: 31147207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ensuring continuing fitness to practice in the pharmacy workforce: Understanding the challenges of revalidation.
    Schafheutle EI; Hassell K; Noyce PR
    Res Social Adm Pharm; 2013; 9(2):199-214. PubMed ID: 23517660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.